Cellectis (CLLS) Non-Current Debt (2014 - 2026)
Cellectis' (CLLS) quarterly Non-Current Debt came in at $67.5 million in Q1 2026, up 32.25% year-on-year from $51.0 million in Q1 2025, and down 8.8% quarter-over-quarter from $74.0 million in Q4 2025.
Cellectis (CLLS) Non-Current Debt (2014 - 2026) Analysis & Trends
Cellectis' Non-Current Debt history runs 12 years deep, the most recent figure standing at $67.5 million for Q1 2026.
- On a quarterly basis, Non-Current Debt rose 32.25% year-over-year to $67.5 million in Q1 2026; TTM through Mar 2026 was $67.5 million, a 32.25% increase from a year earlier, with the FY2025 full-year figure at $74.0 million, up 45.46% from the prior year.
- Non-Current Debt slipped to $67.5 million in Q1 2026 per CLLS's latest filing, from $74.0 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $74.0 million in Q4 2025 and bottomed at $14.7 million in Q3 2022.
- The 5-year median for Non-Current Debt is $50.9 million (2024), against an average of $45.1 million.
- Across the five-year window, Non-Current Debt slumped 35.44% in 2022 and jumped 219.07% in 2024, its largest moves.
- Year by year, Non-Current Debt stood at $20.5 million in 2022, then jumped by 139.27% to $49.1 million in 2023, then increased by 3.58% to $50.9 million in 2024, then soared by 45.46% to $74.0 million in 2025, then decreased by 8.8% to $67.5 million in 2026.
- Per Business Quant, the three latest CLLS Non-Current Debt figures stand at $67.5 million (Q1 2026), $74.0 million (Q4 2025), and $63.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 67.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.50 Mn |
| Dec 31, 2025 | 74.01 Mn |
| Sep 30, 2025 | 63.40 Mn |
| Jun 30, 2025 | 55.86 Mn |
| Mar 31, 2025 | 51.04 Mn |
| Dec 31, 2024 | 50.88 Mn |
| Sep 30, 2024 | 61.58 Mn |
| Jun 30, 2024 | 58.35 Mn |
| Mar 31, 2024 | 62.62 Mn |
| Dec 31, 2023 | 49.13 Mn |
| Sep 30, 2023 | 43.25 Mn |
| Jun 30, 2023 | 40.27 Mn |
| Mar 31, 2023 | 19.63 Mn |
| Dec 31, 2022 | 20.53 Mn |
| Sep 30, 2022 | 14.70 Mn |
| Jun 30, 2022 | 15.64 Mn |
| Mar 31, 2022 | 18.35 Mn |
| Dec 31, 2021 | 20.03 Mn |
| Sep 30, 2021 | 22.77 Mn |
| Jun 30, 2021 | 23.48 Mn |